The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues: Variation in Staining Intensity Due to Choice of Fixative and Storage Time of Tissue Sections
Abstract
The epidermal growth factor receptor (EGFR) is highly expressed in a variety of solid malignant tumors and its expression has been correlated with disease progression and poor survival. With the advent of targeted therapies, especially IMC-C225 (Cetuximab), a monoclonal antibody (MAb) directed against the EGFR, there is an increasing interest in immunohistochemistry (IHC)-based EGFR screening methods using paraffin-embedded tumor specimens to select cancer patients eligible for treatment with Cetuximab. With the EGFRpharmDX kit, a complete assay for demonstration of EGFR is now available. Because no information about the preservation of the EGFR under various conditions of fixation is available, we performed a prospective study on a panel of commonly used fixatives to determine optimal tissue preservation protocols. The stability of the epitope on cut tissue sections stored for a period up to 24 month was also tested using material originating from patients with head and neck cancer, non-small-cell lung carcinomas, and colorectal adeno-carcinomas. Depending on the fixative used and the time of storage of cut tissue sections, a variation in the determined level of EGFR expression was demonstrated compared with the most optimal fixation procedure. (J Histochem Cytochem 52:893–901, 2004)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
Ciardiello, F., & Tortora, G. (2001) · PubMed · Cited by 977
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., D’Andrea, G., Seidman, A., Norton, L., Gunnett, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.904 · Cited by 741
(1996) · PubMed · Cited by 554
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
Baselga, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-2 · Cited by 510
Rusch, V. W., Baselga, J. M., Cordon‐Cardo, C., Orazem, J. P., Zaman, M., Hoda, S. A., McIntosh, J., Kurie, J. M., & Dmitrovsky, E. (1993) · PubMed · Cited by 482
Press, M. F., Hung, G., Godolphin, W. J., & Slamon, D. (1994) · PubMed · Cited by 478
Shin, D. M., Donato, N. J., Perez-Soler, R., Shin, H. J. C., Wu, J. Y., Zhang, P. G. Y., Lawhorn, K., Khuri, F. R., Glisson, B. S., Myers, J. N., et al. (2001) · PubMed · Cited by 322
ARTEAGA, C. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70085-7 · Cited by 302
Targeting HER1/EGFR: A molecular approach to cancer therapy
Arteaga, C. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00185-4 · Cited by 251
Arteaga, C. L. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35642 · Cited by 228
Amplification and over‐expression of the EGFR and erb B‐2 genes in human esophageal adenocarcinomas
Al‐Kasspooles, M., Moore, J. H., Orringer, M. B., & Beer, D. G. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540209 · Cited by 224
BUNNJR, P., & Franklin, W. A. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70089-4 · Cited by 162
Epidermal growth factor receptors in lung tumours
Berger, M. S., Gullick, W. J., Greenfield, C., Evans, S. W., Addis, B. J., & Waterfield, M. D. (1987) · The Journal of Pathology · doi:10.1002/path.1711520408 · Cited by 142
EGFR gene amplification ‐ rearrangement in human glioblastomas
Schwechheimer, K., Huang, S., & Cavenee, W. K. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620206 · Cited by 135
Epidermal growth factor receptor-targeted therapy for pancreatic cancer
XIONG, H., & Abbruzzese, J. L. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70088-2 · Cited by 125
Bunn, P. A., & Franklin, W. A. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35646 · Cited by 119
Worland, P. J., Gray, K., Rolfe, P. M., Gray, K., & Ross, M. J. S. (2003) · American Journal of Clinical Pathology · doi:10.1309/y6lpc0lr726l9dx9 · Cited by 93
Herbst, R. S., & Hong, W. K. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70087-0 · Cited by 88
Oncogenes in head and neck cancer
Irish, J. C., & Bernstein, A. (1993) · The Laryngoscope · doi:10.1288/00005537-199301000-00009 · Cited by 87
Epidermal growth factor receptor-targeted therapy in colorectal cancer
O'Dwyer, P. J., & BENSONIII, A. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70086-9 · Cited by 83
Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines
Yip, Y. L., & Ward, R. L. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s002620100226 · Cited by 68
Hsieh, E., Shepherd, F. A., & Tsao, M. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00116-1 · Cited by 66
Epidermal growth factor receptor expression and measurement in solid tumors
Spaulding, D., & Spaulding, B. O. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70090-0 · Cited by 61
Kearsley, J. H., Leonard, J. H., Wright, R. G., & Walsh, M. D. (1991) · Pathology · doi:10.3109/00313029109063564 · Cited by 57
Epidermal growth factor receptor-targeted therapy in colorectal cancer
O'Dwyer, P. J., & Benson, A. B. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35643 · Cited by 57
Antibody therapy of non-Hodgkin's B-cell lymphoma
Chinn, P. C., Braslawsky, G. R., White, C., & Hanna, N. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0347-6 · Cited by 53
Epidermal growth factor receptor expression and measurement in solid tumors
Spaulding, D. C., & Spaulding, B. O. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35647 · Cited by 49
Cited by
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
Moroni, M., Veronese, S., Benvenuti, S., Marrapese, G., Sartore-Bianchi, A., Di Nicolantonio, F., Gambacorta, M., Siena, S., & Bardelli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70102-9 · Cited by 941
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
Frattini, M., Saletti, P., Romagnani, E., Martin, V, Molinari, F., Ghisletta, M., Camponovo, A., Etienne, L. L., Cavalli, F., & Mazzucchelli, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604009 · Cited by 540
Stewart, J. S. W., Cohen, E. E. W., Licitra, L., Van Herpen, C. M. L., Khorprasert, C., Soulieres, D., Vodvarka, P., Rischin, D., Garin, A. M., Hirsch, F. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0530 · Cited by 382
Biospecimen Reporting for Improved Study Quality (BRISQ)
Moore, H. M., Kelly, A. B., Jewell, S. D., McShane, L. M., Clark, D. P., Greenspan, R., Hayes, D. F., Hainaut, P., Kim, P., Mansfield, E., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200021n · Cited by 337
Metadata
- Authors
- Atkins, D., Reiffen, K.-A., Tegtmeier, C. L., Winther, H., Bonato, M. S., & Störkel, S.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 2004-07
- Volume
- 52
- Issue
- 7
- Pages
- 893-901
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W2138526447
- Cited by
- 319
- References
- 29
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.